RECURSION PHARMACEUTICALS IN's ticker is RXRX and the CUSIP is 75629V104. A total of 128 filers reported holding RECURSION PHARMACEUTICALS IN in Q4 2021. The put-call ratio across all filers is 1.27 and the average weighting 1.8%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Obvious Management Services, L.L.C. | 5,977,631 | $102,397,000 | 87.10% |
| Two Sigma Ventures, LP | 1,806,800 | $30,950,000 | 61.39% |
| DCVC Opportunity Fund II GP, LLC | 3,951,141 | $67,683,000 | 33.92% |
| MV Management XI, L.L.C. | 1,971,908 | $33,779,000 | 14.59% |
| Data Collective IV GP, LLC | 5,941,120 | $101,771,000 | 13.74% |
| ArchPoint Investors | 1,255,430 | $21,506,000 | 6.38% |
| MIC Capital Management UK LLP | 1,388,889 | $23,792,000 | 4.55% |
| HARVARD MANAGEMENT CO INC | 1,509,254 | $25,854,000 | 2.43% |
| Samsara BioCapital, LLC | 539,236 | $9,237,000 | 1.79% |
| Spouting Rock Asset Management, LLC | 90,203 | $1,545,000 | 1.21% |